News

Genfit: publication of GFT 505 clinical results in "Diabete Care"
Interview: They chose the Lille Region for their installation
LILLE ART OF LIVING
AGENDA
SAVE THE DATE: NUTREVENT - June 15-16, 2011 - in Lille
Success Stories: Tate & Lyle
Success Stories: CIGES
Eurasanté Bio-Business Park, the place to set up
NHL: AT THE CROSSROADS OF NUTRITION, BIOTECHNOLOGY AND HEALTH
Osyris Medical receives FDA 510(k) for Lipocontrol Laser Assisted Lipolys System
GFT 505: New clinical trial to consolidate its anti-diabetic potential
Invest for success
Genfit: €2.3 M participating development contract with Oseo
GENFIT: Two major pre-diabetes clinical trials within the IT-Diab Program
EBD Group, Eurasanté and IDIS create a new international pharma-tech transfer event : BioFIT, October 26-27 2010
Genfit: milestone achieved as a coumpound developed in partnership enters the clinic
Genfit extends patent protection on GFT505 in major worldwide countries
Genfit identifies compounds which modulate clock genes for the treatment of cardiometabolic disease and CNS disorders
EuroBiO 2009
GENFIT PROGRESSES IN INNOVATIVE THERAPEUTIC APPROACHES IN ALZHEIMER’S DISEASE
GENFIT and BICOLL announce the identification of active compounds for inflammatory diseases
DIMETEX, Interreg IV programme
Eurasanté at BIO 2008, San Diego
All you need to know about the biotech industry is on EuroBiO 2007
The Nutrition Healthcare Longevity Cluster at BioJapan
A new R&D laboratory for Minakem
EuroBiOpartnering 2007 adopts a clear "tech transfer" focus